[
  {
    "ts": null,
    "headline": "CVS Health declares quarterly dividend",
    "summary": "CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 3, 2025, to holders of record on October 23, 2025.",
    "url": "https://finnhub.io/api/news?id=9bcd1100cce2ba29588f8ab6e8729bc58d8e50bbfa4419fd864fa537fe466705",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758146940,
      "headline": "CVS Health declares quarterly dividend",
      "id": 136797801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 3, 2025, to holders of record on October 23, 2025.",
      "url": "https://finnhub.io/api/news?id=9bcd1100cce2ba29588f8ab6e8729bc58d8e50bbfa4419fd864fa537fe466705"
    }
  },
  {
    "ts": null,
    "headline": "Taylor Sheridan leases his ranch to Paramount for $50K/week — how to generate rental income without an estate",
    "summary": "Real estate as a powerful wealth-building tool.",
    "url": "https://finnhub.io/api/news?id=1ba5faec1a5f613d0ffb6460eb2c4f35eaa66ae8f911271da1c2b1e30f01108f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758136020,
      "headline": "Taylor Sheridan leases his ranch to Paramount for $50K/week — how to generate rental income without an estate",
      "id": 136798352,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Real estate as a powerful wealth-building tool.",
      "url": "https://finnhub.io/api/news?id=1ba5faec1a5f613d0ffb6460eb2c4f35eaa66ae8f911271da1c2b1e30f01108f"
    }
  },
  {
    "ts": null,
    "headline": "Job seekers feel awful about the labor market. Data is finally starting to explain why.",
    "summary": "Job growth is slowing, workers are staying put, and unemployment is starting to creep up.",
    "url": "https://finnhub.io/api/news?id=1d70e0bf7f9e2ffef3947355fc508dd5a9e51e8f566db6b0dd2e266f46be8f30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758129645,
      "headline": "Job seekers feel awful about the labor market. Data is finally starting to explain why.",
      "id": 136791706,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Job growth is slowing, workers are staying put, and unemployment is starting to creep up.",
      "url": "https://finnhub.io/api/news?id=1d70e0bf7f9e2ffef3947355fc508dd5a9e51e8f566db6b0dd2e266f46be8f30"
    }
  },
  {
    "ts": null,
    "headline": "CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?",
    "summary": "CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.",
    "url": "https://finnhub.io/api/news?id=9ce0df0f1f82475e57547394e2ebe966f187d4bfa00cecf0bfa0ba06eea72426",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758129120,
      "headline": "CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?",
      "id": 136791707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.",
      "url": "https://finnhub.io/api/news?id=9ce0df0f1f82475e57547394e2ebe966f187d4bfa00cecf0bfa0ba06eea72426"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says",
    "summary": "Amid a flurry of news out of the world’s leading weight-loss drugmakers  Novo Nordisk  and  Eli Lilly  this week, Berenberg broke with the common Wall Street view that Lilly is the better obesity play.  Novo Nordisk is “no longer the elephant in the room,” analysts led by Kerry Holford said as they upgraded the stock to Buy from Hold Tuesday.  The analysts see opportunities for new CEO Maziar Mike Doustdar to positively surprise investors, even as some hurdles remain.",
    "url": "https://finnhub.io/api/news?id=8287bf6d47aa41b907027b7d5c8311be76a499e4da021bcb45b936df97e40389",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758126360,
      "headline": "Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says",
      "id": 136791565,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Amid a flurry of news out of the world’s leading weight-loss drugmakers  Novo Nordisk  and  Eli Lilly  this week, Berenberg broke with the common Wall Street view that Lilly is the better obesity play.  Novo Nordisk is “no longer the elephant in the room,” analysts led by Kerry Holford said as they upgraded the stock to Buy from Hold Tuesday.  The analysts see opportunities for new CEO Maziar Mike Doustdar to positively surprise investors, even as some hurdles remain.",
      "url": "https://finnhub.io/api/news?id=8287bf6d47aa41b907027b7d5c8311be76a499e4da021bcb45b936df97e40389"
    }
  },
  {
    "ts": null,
    "headline": "Exploring 3 Undervalued Small Caps With Insider Buying In The European Market",
    "summary": "As the European market experiences a cautious optimism with major indices like the STOXX Europe 600 Index rising amid expectations of U.S. interest rate cuts, investors are closely monitoring economic indicators that could impact small-cap companies. In this context, identifying stocks that show potential through factors such as insider buying and favorable economic conditions can provide insights into promising opportunities within the small-cap segment.",
    "url": "https://finnhub.io/api/news?id=2cae49fcd6980f653c196c8929b292ce6bd7e5b7169d1dc8fe3ead28abca9986",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758091175,
      "headline": "Exploring 3 Undervalued Small Caps With Insider Buying In The European Market",
      "id": 136787644,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As the European market experiences a cautious optimism with major indices like the STOXX Europe 600 Index rising amid expectations of U.S. interest rate cuts, investors are closely monitoring economic indicators that could impact small-cap companies. In this context, identifying stocks that show potential through factors such as insider buying and favorable economic conditions can provide insights into promising opportunities within the small-cap segment.",
      "url": "https://finnhub.io/api/news?id=2cae49fcd6980f653c196c8929b292ce6bd7e5b7169d1dc8fe3ead28abca9986"
    }
  }
]